Dubai, UAE, 31st October 2017: Experts from across the region gathered earlier this week at iCaRE – the Middle East’s very first Cardiovascular Regional Experts Symposia 2017, dedicated to promoting heart health by shedding light on the latest cardiac biomarkers towards achieving best practices in patient-care.

With the UAE government taking great strides to reduce deaths due to cardiovascular diseases from 300 per 100,000 of the population to 150 per 100,000 by 2021, and the recently launched Dubai Fitness Challenge; iCare aims to align with government initiatives and support the regions efforts by bringing together the greatest minds in the industry to deliberate on effective actions and solutions. 

Held in Dubai, iCaRE is powered by Roche Diagnostics Middle East (RDME)– the leading IVD partner of choice in the Middle East that brings solutions to support healthcare professionals to address prevention, diagnosis and treatment of diseases. 

Chaired by Professor Abdullah Shehab – President of Emirates Cardiac Society, the symposium hosted multiple panel discussions with specialists discoursing themes ranging from early diagnosis of Acute Coronary Syndrome (ACS), to heart failure management; complete with the evolution of cardiac biomarkers, latest updates in industry practice guidelines, challenges and solutions.

Harald Wolf, General Manager of Roche Diagnostics Middle East (RDME) said, “In keeping with our core principles of innovation and pioneering medical solutions, we are proud to contribute to the medical landscape of the region by launching its first ever cardiovascular symposium. We bring together regional specialists, who are some of the brightest minds in the industry, under one roof.”

The all-day event hosted some of the regions celebrated cardiology experts from renowned entities, such as Professor Khalid Habib, Consultant Interventional Cardiologist and President of the Saudi Heart Association, Professor Waleed Al Habib, Consultant Heart Failure Cardiologist and Assistant Professor of Medicine at King Saud University and other cardiologists from Jordan, Egypt, Lebanon and Oman.

 “This conference, serves as a leap forward in creating diagnostics and treatment solutions that will help to significantly improve patient’s lives, and contribute towards equal advancement in the healthcare sector across the region”, added Harald.

RDME has taken the unprecedented move of being the first IVD Company to have a Management Centre and a logistics hub in the Middle East. RDME has extended its ownership of the entire supply chain, quality control and customer support all the way into the centre of the region. This base of operations reinforces the commitment to global Roche standards and is driven by a full team of vastly experienced specialists offering a complete portfolio of services. With this regional empowerment, RDME has moved its leadership and decision-making closer to its customers and distributors. These investments allow Roche Diagnostics Middle East to develop from being a supplier into becoming the preferred IVD partner for its customers.

RDME offers a complete portfolio of services in 16 countries: UAE, Saudi Arabia, Iraq, Iran, Qatar, Kuwait, Bahrain, Oman, Yemen, Syria, Jordan, Palestine, Lebanon, Egypt, Libya and Maldives. For more information, please visit

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

MOHAP License: I7YLGUJ8-160822